Speakers

Catriona Crombie

Associate Director for Technology Transfer and Rare Disease Challenge Lead

LifeArc

Ruiz Astigarraga

Head of EU Technical Operations

Galapagos

Jeremy Skillington

CEO

Poolbeg Pharma

Eric Halioua

President & Chief Executive Officer

PDC*line Pharma

Lindsay Davies

Chief Scientific Officer

NextCell Pharma

Florence Salmon

VP Regulatory Affairs

HOOKIPA Pharma Inc.

Giovanni Ganendra

Senior Scientist - Gene Therapy Process and Analytical Sciences

UCB Pharma

Ben Weil

Director of Manufacturing

INmune Bio

John Bridgeman

Director of Cell Therapy Research

Instil Bio

Lee Buckler

Senior VP of Advanced Therapies

BCA Advanced Therapies Network

Michela Castellani-Kleinschroth

Head of MS&T, SKAN

Aseptic Technologies

Aled Charles

Process Development Director

Rentschler Biopharma

Thomas Chattaway

Senior Life Science Consultant

Independent

Jason Dowd

Global Lead Cell Therapy Platform Process

Bayer

Mark Duerkop

Chief Executive Officer

Novasign, Austria

Larry Forman

CEO

CHO PLUS

Dr George Frodsham

Founder & CEO

Medisieve

Dr. Clair Gallagher

Infrastructure Manager

CONCEPT (NIBRT)

Joe Gallagher

Technical Applications Manager, Cell & Gene Therapy

Avantor

Surabhi Godbole

Scientist I

Epic Bio

Conor Grogan

Industrial Software Sales Manager

Emerson Automation Solutions

Martina Hennessy

Director

Wellcome HRB Clinical Research Facility at St. James’s Hospital

Margit Holzer, Ph.D.

Senior Scientific Director

Ulysse Consult S.a.r.L

Dr. Lilian Hook

Director, Cell Apheresis and Gene Therapies

NHS Blood and Transplant

Frederik Jaenen

VP Sales

Bluecrux

Pierce Kent

Head of CGT Supply Chain

Roche

Yu-Tsan (Richard) Liu

Sr. Scientist

UCB Pharma

Rory Mullen

Head of BioPharma and Food

IDA Ireland, Ireland

Rob Noel

Independent Consultant

55Biomarkets

Mohamed Noor, PhD

Digitalization Manager

National Institute for Bioprocessing Research and Training (NIBRT)

Eimear O'Leary

Director of Communications and Advocacy

Irish Pharmaceutical Healthcare Association, Ireland

Irene Pino

Technology Transfer Manager

Spanish National Cancer Research Centre (CNIO)

Dr. Maria Prencipe

Assistant Professor of Pharmacology, School of Biomolecular and Biomedical Science, University College Dublin & co-lead of the Cancer Biology and Therapeutics laboratory, UCD Conway Institute

University College Dublin

Pranav Puri, PhD

Head Process Development

VectorY

Gerardo Santiago Toledo

Director, Cell Process Development

Autolus Therapeutics

Ian Scanlon

Fiber Development Lead

Astrea Bioseparations

Jordan Schecter

VP, Multiple Myeloma

Johnson & Johnson

Dr Alok Tanala Patra

Scientist

A*STAR Bioprocessing Technology Institute

Kristian Tryggvason

Co-Founder, CEO

Alder Therapeutics

Mikko Turunen, PhD

Founder and CSO

RNatives Inc.

Koji Ushioda

President SKAN Japan

Aseptic Technolgies

Dr Hiro Usuda

Scouting & Transaction Lead, Business Development

Astellas Pharma Europe

Johan Zebib

MES Sales Leader

Emerson